HomeTRML • NASDAQ
Tourmaline Bio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.23M | 49.75% |
Net income | -22.97M | -72.56% |
Net profit margin | — | — |
Earnings per share | -0.89 | -61.82% |
EBITDA | -26.22M | -49.76% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 249.31M | -14.93% |
Total assets | 287.50M | -19.95% |
Total liabilities | 7.64M | 51.79% |
Total equity | 279.86M | — |
Shares outstanding | 25.69M | — |
Price to book | 1.42 | — |
Return on assets | -21.99% | — |
Return on capital | -22.60% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -22.97M | -72.56% |
Cash from operations | -21.68M | -45.27% |
Cash from investing | 25.94M | 113.73% |
Cash from financing | 562.00K | -99.65% |
Net change in cash | 4.82M | 111.37% |
Free cash flow | -13.67M | -26.09% |
Previous close
$15.50
Day range
$14.88 - $15.70
Year range
$11.56 - $29.79
Market cap
399.07M USD
Avg Volume
341.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website
Employees
74
